JW Asset Management, LLC
- SEC CIK
- 0001549738
- Latest filing
- Aug 7, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 9, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 17
- +2 vs. Q3 2023
- Portfolio value
- $175.2M
- −$55.7M (−24.1%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ESTAEstablishment Labs Holdings Inc. | COM | 3,192,485 | $82.7M | 47.2% | 00.0% | Unchanged | History |
| CELHCelsius Holdings, Inc. | COM NEW | 303,000 | $16.5M | 9.4% | +3,000+1.0% | AddedConverted for a 3-for-1 split | History |
| LLYEli Lilly & Co | Stock | 27,000 | $15.7M | 9.0% | 00.0% | Unchanged | History |
| NVONovo Nordisk A S | ADR | 118,200 | $12.2M | 7.0% | 00.0% | Unchanged | History |
| NVDANVIDIA Corp | Stock | 24,625 | $12.2M | 7.0% | +9,625+64.2% | Added | History |
| COCOVita Coco Company, Inc. | COM | 345,621 | $8.87M | 5.1% | 00.0% | Unchanged | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 413,392 | $6.95M | 4.0% | −150,000−26.6% | Reduced | History |
| Advisorshares Tr00768Y453 | PURE US CANN ETF | 701,002 | $4.91M | 2.8% | +701,002 | New | – |
| HRTXHeron Therapeutics, Inc. | COM | 2,292,418 | $3.90M | 2.2% | −115,000−4.8% | Reduced | History |
| ANFAbercrombie & Fitch Co | CL A | 35,000 | $3.09M | 1.8% | +35,000 | New | History |
| SNAPSnap Inc | Stock | 170,000 | $2.88M | 1.6% | +170,000 | New | History |
| IDRIdaho Strategic Resources, Inc. | COM NEW | 271,697 | $1.72M | 1.0% | 00.0% | Unchanged | History |
| ETNEaton Corp plc | Stock | 5,000 | $1.20M | 0.7% | 00.0% | Unchanged | History |
| CATCaterpillar Inc | Stock | 4,024 | $1.19M | 0.7% | 00.0% | Unchanged | History |
| FAZEFaZe Holdings Inc. | COMMON STOCK | 3,126,319 | $562.7K | 0.3% | 00.0% | Unchanged | History |
| ETF Managers Tr26924G508 | ETFMG ALTR HRVST | 127,797 | $412.8K | 0.2% | +127,797 | New | – |
| HITIHigh Tide Inc. | COM NEW | 102,144 | $166.5K | 0.1% | +27,144+36.2% | Added | History |
Sold out since Q3 2023 (2)
Positions held at the end of Q3 2023 that are gone from this filing.